Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amgen Inc. buy Dbs Bank

Start price
€300.00
20.09.24 / 50%
Target price
-
20.09.25
Performance (%)
-19.03%
End price
€242.90
21.09.25
Summary
This prediction ended on 21.09.25 with a price of €242.90. The prediction for Amgen Inc. disappointed with a performance of -19.03%. Dividends of €9.15 are taken into consideration when calculating the performance. Dbs_Bank has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Amgen Inc. 0.290% 0.290% 7.389%
iShares Core DAX® 0.795% 1.458% 17.980%
iShares Nasdaq 100 -3.088% -0.762% 3.169%
iShares Nikkei 225® -0.952% -2.268% 12.208%
iShares S&P 500 -1.393% 0.199% 1.698%

Comments by Dbs_Bank for this prediction

In the thread Amgen Inc. diskutieren

Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at Dbs Bank to a "strong-buy" rating.
Ratings data for AMGN provided by MarketBeat

In the thread Trading Amgen Inc.
Prediction Buy
Perf. (%) -19.03%
Target price
Change
Ends at 20.09.25

Die von Dbs_Bank gewählte maximale Laufzeit wurde überschritten